Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality (Q96126395)
Jump to navigation
Jump to search
scientific article published on 03 June 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality |
scientific article published on 03 June 2020 |
Statements
Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality (English)
Feng Zhou
Ye-Mao Liu
Jing Xie
Haomiao Li
Fang Lei
Huilin Yang
Jingjing Cai
Xiao-Jing Zhang
Bin Wu
Meng Xia
Da Xiang
Chengzhang Yang
Xin-Liang Ma
Qingbo Xu
Zhigang Lu
Haofeng Lu
Xigang Xia
Daihong Wang
Xiaofeng Liao
Gang Peng
Jun Yang
Xiaodong Huang
Bing-Hong Zhang
Yufeng Yuan
Xiang Wei
Peter P Liu
Yibin Wang
Peng Zhang
Zhi-Gang She
Jiahong Xia